112667-17-1 | Olean-12-en-28-oicacid, 3-[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]-16-hydroxy-, (3b,16a)- | C38H61 N O9 |
112667-54-6 | 2(3H)-Furanone,dihydro-4-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]-3-[(3,4,5-trimethoxyphenyl)methyl]-,(3R,4R)- | C23H28 O8 |
112667-45-5 | Picrasane-1,16-dione,2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-,(2a,11a,12a)- (9CI) | C26H40 O11 |
112667-08-0 | b-D-Galactopyranoside, (3b,5a,20R)-20-[[2,6-dideoxy-3-O-(2,6-dideoxy-3-O-methyl-b-D-lyxo-hexopyranosyl)-b-D-arabino-hexopyranosyl]oxy]-17-hydroxypregn-6-en-3-yl6-deoxy- (9CI) | C40H66 O13 |
112667-14-8 | Lanosta-7,9(11),24-trien-26-oicacid, 15,22-bis(acetyloxy)-3-hydroxy-, (3a,15a,22S,24E)- (9CI) | C34H50 O7 |
112667-07-9 | b-D-Galactopyranoside, (3b,5a,20R)-20-[(2,6-dideoxy-b-D-arabino-hexopyranosyl)oxy]-17-hydroxypregn-6-en-3-yl6-deoxy- (9CI) | C33H54 O10 |
112667-09-1 | Erigeside C | C15H20 O10 |
112667-06-8 | b-D-Galactopyranoside, (3b,5a,20R)-17,20-dihydroxypregn-6-en-3-yl 6-deoxy-,3-acetate (9CI) | C29H46 O8 |
112667-34-2 | Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI) | C78H136 N28 O22 S4 |
112667-05-7 | b-D-Galactopyranoside, (3b,5a,20R)-17,20-dihydroxypregn-6-en-3-yl 6-deoxy- (9CI) | C27H44 O7 |
112667-20-6 | Benzenecarboximidamide, 4,4'-[1,5-pentanediylbis(oxy)]bis-,monomethanesulfonate | C19H24N4O2.CH4O3S |
112667-24-0 | L-Alanine, L-glutaminyl-L-lysyl-L-alanyl-L-lysyl-L-isoleucyl-L-a-glutamyl-L-valyl-L-seryl-L -a-glutamyl-L-a-aspartylglycyl-L-threonyl-L-lysyl- | C63H110N18O24 |
112667-28-4 | Propanoic acid, 3-[[1-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-phenylethyl]amino]-3- oxo- | C26H24N2O5 |
112667-36-4 | 3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-[2,6-bis(1,1-dimethylethyl)phenoxy]hexamethyl- | C38H70O10 |